Tag: Editas Medicine

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Editas Medicine

Crispr and Cas Gene Market to Hit $6.47 Billion by 2030: Coherent Market ... - Yahoo Finance

Added to Collection on: 2023-12-04 17:11:48

Tags for this article:

Genome editing
Genetic engineering
Biotechnology
Jennifer Doudna
Molecular biology
Intellia Therapeutics
Mammoth Biosciences
CRISPR Therapeutics
CRISPR
Editas Medicine
Gene therapy
Cas9

Click the tags to see associated articles and topics

View Article Details
Intellia to lay off staff, cut some early research | BioPharma Dive

Added to Collection on: 2024-01-05 17:59:38

Tags for this article:

Intellia Therapeutics
Biotechnology
Gene therapy
Genetic engineering
Genome editing
Amyloidosis
CRISPR Therapeutics
Familial amyloid polyneuropathy
Editas Medicine
CRISPR
Gene editing
Human Nature
Intellia
United States

Click the tags to see associated articles and topics

View Article Details
CRISPR Gene Editing Market Projected to Hit USD 9.2 Billion by 2030 with a CAGR of 22.6%

Added to Collection on: 2024-01-30 20:38:20

Tags for this article:

Biotechnology
Genome editing
Molecular biology
Genetic engineering
Biological engineering
CRISPR gene editing
CRISPR
Intellia Therapeutics
Guide RNA
Editas Medicine
Beam Therapeutics
Gene therapy
CRISPR Therapeutics

Click the tags to see associated articles and topics

View Article Details
Gene Editing Improves Vision for People with Retinal Disease - Mass General Brigham

Added to Collection on: 2024-05-20 19:32:51

Tags for this article:

Biotechnology
Genetic engineering
Genome editing
Molecular biology
Biological engineering
CRISPR gene editing
CRISPR
Editas Medicine
Retinal degeneration
Retina
Vision Institute

Click the tags to see associated articles and topics

View Article Details
Vertex (VRTX) Ups Investment in CRISPR Gene Therapy Partnership

Added to Collection on: 2024-05-26 17:06:08

Tags for this article:

Gene therapy
CRISPR Therapeutics
Genome editing
Genetic engineering
Vertex Pharmaceuticals
Biotechnology
Intellia Therapeutics
Editas Medicine
Regenerative Medicine Advanced Therapy
Beam Therapeutics
Exagamglogene autotemcel
CRSP
Therapeutics AG
CRISPR Therapeutics AG

Click the tags to see associated articles and topics

View Article Details
Editas Medicine, Inc. (NASDAQ:EDIT) Shares Acquired by Trexquant Investment LP

Added to Collection on: 2024-05-26 17:17:00

Tags for this article:

Gene therapy
Editas Medicine
Equity securities
Stock market
Financial markets
Stock
Rate of return
Trexquant Investment LP
Editas Medicine Inc

Click the tags to see associated articles and topics

View Article Details
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought - The Globe and Mail

Added to Collection on: 2024-06-09 15:33:36

Tags for this article:

Intellia Therapeutics
Gene therapy
CRISPR Therapeutics
Vertex Pharmaceuticals
Familial amyloid polyneuropathy
Biotechnology
Locus Biosciences
Editas Medicine
Cathie Wood

Click the tags to see associated articles and topics

View Article Details
VCs investing in cell engineering for drug discovery - Vator News

Added to Collection on: 2024-07-30 21:25:02

Tags for this article:

Biotechnology
Molecular genetics
Molecular biology
Genetic engineering
RNA
RNA interference
Gene therapy
CRISPR gene editing
Alnylam Pharmaceuticals
Editas Medicine
Stem cell
Synthetic biology

Click the tags to see associated articles and topics

View Article Details
North America Leber Congenital Amaurosis (LCA) Market By Application - Third Eye News

Added to Collection on: 2024-09-15 23:51:26

Tags for this article:

Eye diseases
Leber congenital amaurosis
Gene therapy
Medical genetics
Molecular biology
Editas Medicine
Amaurosis
LCA
Visual impairment
Leber

Click the tags to see associated articles and topics

View Article Details
Where Editas Medicine Stands With Analysts - Benzinga

Added to Collection on: 2024-09-17 21:46:11

Tags for this article:

Gene therapy
Editas Medicine
Valuation
Financial market
Return on equity

Click the tags to see associated articles and topics

View Article Details